Beyond the PSA: The hidden costs of screening in prostate cancer

被引：0
|
作者：
Sanyal, Chiranjeev [1 ]
Ragavan, Meera V. [2 ]
机构：
[1] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada
[2] Kaiser Permanente, Div Res, Pleasanton, CA USA
来源：
CANCER | 2024年 / 130卷 / 19期
关键词：
BURDEN;
D O I：
10.1002/cncr.35474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The diagnostic workup following a positive prostate-specific antigen test may lead to significant out-of-pocket costs for patients. Providers should incorporate costs into shared decision-making with patients; in parallel, policymakers and payers must identify solutions to mitigate financial burdens that risk widening existing disparities in prostate cancer care.
引用
收藏
页码：3272 / 3274
页数：3
相关论文
共 50 条
  • [41] History of PSA screening on prostate cancer aggressiveness.
    Cullen, Jennifer
    Gerald, Thomas
    Burke, Allen
    Kuo, Huai-Ching
    Rosner, Inger L.
    Srivastava, Shiv
    Sesterhenn, Isabell
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] PSA testing: an evolving relationship with prostate cancer screening
    J Constantinou
    M R Feneley
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 6 - 13
  • [43] PSA Screening and Prostate Cancer Mortality-Reply
    Turner, Emma L.
    Metcalfe, Chris
    Martin, Richard M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (10):
  • [44] Prostate-Cancer Mortality after PSA Screening
    Wolf, Andrew M. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23): : 2230 - 2230
  • [45] THE EFFECT OF THE 2012 USPSTF ON PSA FOR PROSTATE CANCER SCREENING
    Stein, Barry
    Smith, Cynthia
    Feustel, Paul
    JOURNAL OF UROLOGY, 2018, 199 (04): : E764 - E764
  • [46] Performance characteristics of PSA density for prostate cancer screening
    Sotelo, RJ
    Novoa, J
    Karam, O
    Mora, KE
    Perez, H
    Keklikian, W
    De Andrade, R
    Carmona, O
    Loeb, S
    Catalona, WJ
    JOURNAL OF UROLOGY, 2006, 175 (04): : 479 - 479
  • [47] Does PSA screening reduce prostate cancer mortality?
    Vis, AN
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (05) : 600 - 601
  • [48] What are the operating characteristics of PSA screening for prostate cancer?
    Robert E Reiter
    Benjamin Shurtleff
    Nature Clinical Practice Urology, 2006, 3 : 74 - 75
  • [49] METASTATIC PROSTATE CANCER IN THE MODERN ERA OF PSA SCREENING
    Fontenot, Philip
    Nehra, Avinash
    Wyre, Hadley
    Mirza, Moben
    Holzbeierlein, Jeffrey
    Thrasher, J. Brantley
    Van Veldhuizen, Peter
    Lee, Eugene
    JOURNAL OF UROLOGY, 2015, 193 (04): : E824 - E825
  • [50] Reconsidering Prostate Cancer Mortality - The Future of PSA Screening
    Welch, H. Gilbert
    Albertsen, Peter C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1557 - 1563
12345